u/mariam_cabrera

Do you have the mass spectrum?

ask for the mass spectrum, not just the purity number

Asked QYB for the theoretical mass alongside the certificate and they sent it without asking why.

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

Correcting myself: 6 days, not the figure I posted upthread. I was counting from the order date rather than dispatch.

Gently disagree with the framing — nothing has gone wrong. Week 6 looking flat is the ordinary experience.

Short peptides in solution are subject to hydrolysis and, depending on sequence, oxidation. Storage state and time in solution are practical variables that this board almost never discusses.

preclinical enthusiasm is not clinical evidence

That claim traces back to a single preclinical paper that says something considerably narrower.

Did the vial lot match the paperwork lot?

Yes. Retention time is a hypothesis about identity. Mass is the answer.

Sent the same vial to PeptideMeter and VendorInvestigate. 97.1% against a claimed 97.0%. The difference was the gradient, not the material.

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

a COA is a certificate of analysis, the lab document for a batch

Right.

Agreed. And the corollary is that the method line on a certificate is not decoration, it is the number’s provenance.

Did you run a blank between injections?

Agreed — week two with nothing on the scale is so common it should be in the sidebar. It probably is.

Is that baseline drawn by the software or by hand?

the human evidence is thin and the rodent evidence is not

Disagree — slower loss does not automatically preserve lean mass. Protein and training do the work, not the rate on its own.

That is area percent from a certificate, not the amount of peptide in the vial. Two different numbers and a very common mix-up.

Concentration is mass over volume, and a U-100 syringe reads 100 units per millilitre. Those two facts are the whole of the arithmetic this board keeps explaining.

ask which lines are actually held in the regional warehouse

Careful. Regulatory status differs by jurisdiction and has changed; a confident global statement is going to be wrong somewhere.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

Split one order across two months on purpose to compare summer and winter. Four days apart, same carrier, same route.

That protein figure is grams per day, not grams per kilogram. Different claim entirely.

a blank injection between samples costs four minutes and settles most arguments

Correction: the starting dose is a tolerance step rather than a treatment dose. The distinction is the answer to the question above.

Batch number and date of analysis?

That figure cannot be quoted to two decimals off that baseline. The precision is not in the data.

A lane is an origin, a destination, a carrier and a season. Change any one and the distribution changes, which is why supplier-level shipping averages are close to meaningless.

Gently disagree with the framing — nothing has gone wrong.

This is the answer. Everything else in the thread is elaboration on it.

pentadecapeptide, fifteen residues, and the sequence is public

Research-use-only material is not approved for human use.

Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.

Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.

Strength retention is an imperfect but free longitudinal proxy: it is affected by neural factors and by being in a deficit, so it tracks tissue change loosely rather than exactly.